FDA's New Cybersecurity Era: Why SBOMs and Secure Architecture are Non-Negotiable for MedTech by 2026 Podcast By cover art

FDA's New Cybersecurity Era: Why SBOMs and Secure Architecture are Non-Negotiable for MedTech by 2026

FDA's New Cybersecurity Era: Why SBOMs and Secure Architecture are Non-Negotiable for MedTech by 2026

Listen for free

View show details
This episode examines how U.S. FDA regulations have repositioned cybersecurity as a core feature of medical devices. We discuss the impact of the Consolidated Appropriations Act of 2023 and the FDA's "Refuse to Accept" policy, exploring why a secure architecture, a Software Bill of Materials (SBOM), and robust incident response plans are now critical for regulatory approval, hospital trust, and commercial success heading into 2026. - What new authority did the FDA gain over medical device cybersecurity in 2023? - Why is a Software Bill of Materials (SBOM) now a mandatory part of FDA submissions? - How has "secure by design" shifted from a best practice to a regulatory necessity? - What are the essential components of a compliant post-market cybersecurity plan? - How will a device's security posture directly influence hospital purchasing decisions by 2026? - What is the FDA's "Refuse to Accept" policy for cybersecurity? - How can manufacturers prepare their technical dossiers for these new requirements? Pure Global offers end-to-end consulting for MedTech and IVD companies, helping you navigate complex regulatory landscapes like the FDA's new cybersecurity rules. Our experts develop efficient regulatory strategies and use advanced AI to compile and submit technical dossiers that meet these stringent new standards. We act as your local representative to ensure continuous compliance and monitor regulatory changes that could impact your market access. Let us help you get to market faster. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
No reviews yet